TGF-β-HAS2-HA: Seki and coworkers delineated another downstream route of TGF-β mediated HSC activation in liver fibrosis, which ends in hyaluronan (HA) production, a major ECM glycosaminoglycan, and biomarker of liver cirrhosis. Here, HAS2 is linked to Hepatic fibrosis.